Robert Michiels

Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland.

Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003.

FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium.

415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany.

Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA.

CoreValve SA develops implants and instruments for heart surgery. It offers aortic bioprostheses, delivery catheters, disposable loading systems and other related products. The company was founded by Jacques Seguin in 2001 and is headquartered in Paris, France.

Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents